List of Tables
Table 1. Global Long-acting Anti-HIV Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Long-acting Anti-HIV Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Long-acting Anti-HIV Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Long-acting Anti-HIV Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Long-acting Anti-HIV Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Long-acting Anti-HIV Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Long-acting Anti-HIV Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Long-acting Anti-HIV Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Long-acting Anti-HIV Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Long-acting Anti-HIV Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Long-acting Anti-HIV Drug, Product Type & Application
Table 12. Global Key Manufacturers of Long-acting Anti-HIV Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Long-acting Anti-HIV Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Anti-HIV Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Long-acting Anti-HIV Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Long-acting Anti-HIV Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Long-acting Anti-HIV Drug Sales Market Share by Region (2020-2025)
Table 19. Global Long-acting Anti-HIV Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Long-acting Anti-HIV Drug Sales Market Share by Region (2026-2031)
Table 21. Global Long-acting Anti-HIV Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Long-acting Anti-HIV Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Long-acting Anti-HIV Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Long-acting Anti-HIV Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Long-acting Anti-HIV Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Long-acting Anti-HIV Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Long-acting Anti-HIV Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Long-acting Anti-HIV Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Long-acting Anti-HIV Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Long-acting Anti-HIV Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Long-acting Anti-HIV Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Long-acting Anti-HIV Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Long-acting Anti-HIV Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Long-acting Anti-HIV Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Long-acting Anti-HIV Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Long-acting Anti-HIV Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Long-acting Anti-HIV Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Long-acting Anti-HIV Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Long-acting Anti-HIV Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Long-acting Anti-HIV Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Long-acting Anti-HIV Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Long-acting Anti-HIV Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Long-acting Anti-HIV Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Long-acting Anti-HIV Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Long-acting Anti-HIV Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Long-acting Anti-HIV Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Long-acting Anti-HIV Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Long-acting Anti-HIV Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Long-acting Anti-HIV Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Long-acting Anti-HIV Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Long-acting Anti-HIV Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Long-acting Anti-HIV Drug Sales Market Share by Type (2020-2025)
Table 53. Global Long-acting Anti-HIV Drug Sales Market Share by Type (2026-2031)
Table 54. Global Long-acting Anti-HIV Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Long-acting Anti-HIV Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Long-acting Anti-HIV Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Long-acting Anti-HIV Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Long-acting Anti-HIV Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Long-acting Anti-HIV Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Long-acting Anti-HIV Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Long-acting Anti-HIV Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Long-acting Anti-HIV Drug Sales Market Share by Application (2020-2025)
Table 63. Global Long-acting Anti-HIV Drug Sales Market Share by Application (2026-2031)
Table 64. Global Long-acting Anti-HIV Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Long-acting Anti-HIV Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Long-acting Anti-HIV Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Long-acting Anti-HIV Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Long-acting Anti-HIV Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Long-acting Anti-HIV Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Gilead Company Information
Table 71. Gilead Description and Business Overview
Table 72. Gilead Long-acting Anti-HIV Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Gilead Long-acting Anti-HIV Drug Product
Table 74. Gilead Recent Developments/Updates
Table 75. ViiV Healthcare Company Information
Table 76. ViiV Healthcare Description and Business Overview
Table 77. ViiV Healthcare Long-acting Anti-HIV Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. ViiV Healthcare Long-acting Anti-HIV Drug Product
Table 79. ViiV Healthcare Recent Developments/Updates
Table 80. Janssen Company Information
Table 81. Janssen Description and Business Overview
Table 82. Janssen Long-acting Anti-HIV Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Janssen Long-acting Anti-HIV Drug Product
Table 84. Janssen Recent Developments/Updates
Table 85. Tibotec Company Information
Table 86. Tibotec Description and Business Overview
Table 87. Tibotec Long-acting Anti-HIV Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Tibotec Long-acting Anti-HIV Drug Product
Table 89. Tibotec Recent Developments/Updates
Table 90. Cipla Company Information
Table 91. Cipla Description and Business Overview
Table 92. Cipla Long-acting Anti-HIV Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Cipla Long-acting Anti-HIV Drug Product
Table 94. Cipla Recent Developments/Updates
Table 95. Frontier Biopharmaceutical (Nanjing) Co., Ltd. Company Information
Table 96. Frontier Biopharmaceutical (Nanjing) Co., Ltd. Description and Business Overview
Table 97. Frontier Biopharmaceutical (Nanjing) Co., Ltd. Long-acting Anti-HIV Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Frontier Biopharmaceutical (Nanjing) Co., Ltd. Long-acting Anti-HIV Drug Product
Table 99. Frontier Biopharmaceutical (Nanjing) Co., Ltd. Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Long-acting Anti-HIV Drug Distributors List
Table 103. Long-acting Anti-HIV Drug Customers List
Table 104. Long-acting Anti-HIV Drug Market Trends
Table 105. Long-acting Anti-HIV Drug Market Drivers
Table 106. Long-acting Anti-HIV Drug Market Challenges
Table 107. Long-acting Anti-HIV Drug Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Long-acting Anti-HIV Drug
Figure 2. Global Long-acting Anti-HIV Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Long-acting Anti-HIV Drug Market Share by Type: 2024 & 2031
Figure 4. CAB Long-acting Injection Product Picture
Figure 5. RPV Long-acting Injection Product Picture
Figure 6. Global Long-acting Anti-HIV Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Long-acting Anti-HIV Drug Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Long-acting Anti-HIV Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Long-acting Anti-HIV Drug Market Size (2020-2031) & (US$ Million)
Figure 13. Global Long-acting Anti-HIV Drug Sales (2020-2031) & (K Units)
Figure 14. Global Long-acting Anti-HIV Drug Average Price (US$/Unit) & (2020-2031)
Figure 15. Long-acting Anti-HIV Drug Report Years Considered
Figure 16. Long-acting Anti-HIV Drug Sales Share by Manufacturers in 2024
Figure 17. Global Long-acting Anti-HIV Drug Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Long-acting Anti-HIV Drug Players: Market Share by Revenue in Long-acting Anti-HIV Drug in 2024
Figure 19. Long-acting Anti-HIV Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Long-acting Anti-HIV Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Long-acting Anti-HIV Drug Sales Market Share by Country (2020-2031)
Figure 22. North America Long-acting Anti-HIV Drug Revenue Market Share by Country (2020-2031)
Figure 23. United States Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Long-acting Anti-HIV Drug Sales Market Share by Country (2020-2031)
Figure 26. Europe Long-acting Anti-HIV Drug Revenue Market Share by Country (2020-2031)
Figure 27. Germany Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Long-acting Anti-HIV Drug Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Long-acting Anti-HIV Drug Revenue Market Share by Region (2020-2031)
Figure 34. China Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Long-acting Anti-HIV Drug Sales Market Share by Country (2020-2031)
Figure 42. Latin America Long-acting Anti-HIV Drug Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Long-acting Anti-HIV Drug Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Long-acting Anti-HIV Drug Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Long-acting Anti-HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Long-acting Anti-HIV Drug by Type (2020-2031)
Figure 52. Global Revenue Market Share of Long-acting Anti-HIV Drug by Type (2020-2031)
Figure 53. Global Long-acting Anti-HIV Drug Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Long-acting Anti-HIV Drug by Application (2020-2031)
Figure 55. Global Revenue Market Share of Long-acting Anti-HIV Drug by Application (2020-2031)
Figure 56. Global Long-acting Anti-HIV Drug Price (US$/Unit) by Application (2020-2031)
Figure 57. Long-acting Anti-HIV Drug Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
